Genetic regulation of mouse glycosylphosphatidylinositol-phospholipase D

Article


Flores-Borja, F., Kieszkievicz, J., Church, V., Francis-West, P., Schofield, J., Rademacher, T. and Lund, T. 2004. Genetic regulation of mouse glycosylphosphatidylinositol-phospholipase D. Biochimie. 86 (4-5), pp. 275-282. https://doi.org/10.1016/j.biochi.2004.04.003
TypeArticle
TitleGenetic regulation of mouse glycosylphosphatidylinositol-phospholipase D
AuthorsFlores-Borja, F., Kieszkievicz, J., Church, V., Francis-West, P., Schofield, J., Rademacher, T. and Lund, T.
Abstract

Glycosylphosphatidylinositol phospholipase D (GPI-PLD) has been proposed to be responsible for cleaving membrane-associated glycosylphosphatidyl inositol (GPI) molecules to generate inositol phosphoglycan (IPGs), which have growth factor-mimetic properties. We have cloned the mouse liver GPI-PLD cDNA, which has a sequence that differs from that previously isolated from a mouse glucagonoma cell library. Using a highly specific and very sensitive RNase protection assay, we found that the GPI-PLD expressed in adult/post-natal brain, antrum and insulin-producing cells is identical to that isolated from liver. The expression of mouse GPI-PLD in liver shows a complex genetic regulation with a mouse strain-specific variation. In addition, GPI-PLD mRNA levels were higher in 4-week old animals compared to older animals, and the GPI-PLD mRNA levels increased in mice that developed insulin dependent type 1 diabetes spontaneously. This suggests that the expression of liver GPI-PLD in mice is highly regulated.

PublisherElsevier
JournalBiochimie
ISSN0300-9084
Publication dates
PrintApr 2004
Publication process dates
Deposited12 Feb 2010
Output statusPublished
Digital Object Identifier (DOI)https://doi.org/10.1016/j.biochi.2004.04.003
LanguageEnglish
Permalink -

https://repository.mdx.ac.uk/item/82316

  • 22
    total views
  • 0
    total downloads
  • 1
    views this month
  • 0
    downloads this month

Export as

Related outputs

Locating functionalized gold nanoparticles using electrical impedance tomography
Bayford, R., Damaso, R., Neshatvar, N., Ivanenko, Y., Rademacher, T., Wu, Y., Seifnaraghi, N., Ghali, L., Patel, N., Roitt, I., Nordebo, S. and Demosthenous, A. 2022. Locating functionalized gold nanoparticles using electrical impedance tomography. IEEE Transactions on Biomedical Engineering. 69 (1), pp. 494-502. https://doi.org/10.1109/TBME.2021.3100256
Nanoparticle electrical impedance tomography
Bayford, R., Nordebo, S., Roitt, I., Rademacher, T., Damaso, R., Wu, Y., Seifnaraghi, N. and Demosthenous, A. 2017. Nanoparticle electrical impedance tomography. 18th International Conference on Biomedical Applications of Electrical Impedance Tomography. Hanover, New Hampshire, USA 21 - 24 Jun 2017 Thayer School of Engineering at Dartmouth. pp. 56-56 https://doi.org/10.5281/zenodo.557093
Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
Bayford, R., Rademacher, T., Roitt, I. and Wang, S. 2017. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review. Physiological Measurement. 38 (8). https://doi.org/10.1088/1361-6579/aa7182
The influence of ligand organization on the rate of uptake of gold nanoparticles by colorectal cancer cells
Lund, T., Callaghan, M., Williams, P., Turmaine, M., Bachmann, C., Rademacher, T., Roitt, I. and Bayford, R. 2011. The influence of ligand organization on the rate of uptake of gold nanoparticles by colorectal cancer cells. Biomaterials. 32 (36), pp. 9776-9784. https://doi.org/10.1016/j.biomaterials.2011.09.018
Detection of cancer.
Bayford, R., Roitt, I., Rademacher, T., Demosthenous, A. and Iles, R. 2010. Detection of cancer.
Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells.
Kvirkvelia, N., Vojnovic, I., Warner, T., Athie-Morales, V., Free, P., Rayment, N., Chain, B., Rademacher, T., Lund, T., Roitt, I. and Delves, P. 2002. Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells. Clinical & Experimental Immunology. 127 (2), pp. 263-269. https://doi.org/10.1046/j.1365-2249.2002.01718.x